Bacterial peptidoglycan precursor units (Lipid II)

Bacterial peptidoglycan precursor units, commonly known as lipid II, are the monomeric building blocks essential for synthesizing peptidoglycan, the primary structural component of the bacterial cell wall. These units consist of a disaccharide (N-acetylglucosamine linked β-1,4 to N-acetylmuramic acid) attached to a short peptide stem (typically L-Ala-D-iGlu-mDAP-D-Ala-D-Ala or variants), anchored via a undecaprenyl pyrophosphate lipid tail that facilitates translocation across the cytoplasmic membrane. In peptidoglycan biosynthesis, lipid II serves as the substrate for glycosyltransferases, which polymerize the glycan chains, and transpeptidases (PBPs), which form cross-links between peptide stems to create a rigid meshwork that withstands osmotic pressure and maintains cell shape during growth and division. Disruption of these precursors is a key antibacterial strategy, as β-lactam antibiotics mimic the D-Ala-D-Ala terminus to covalently inhibit PBPs, halting cross-linking and leading to cell lysis. This target is exploited in treating bacterial infections, though resistance arises from PBP alterations reducing drug affinity. Lipid II's role extends to immune recognition, where fragments like muramyl dipeptide activate host Nod-like receptors to trigger innate immunity against infection. Overall, these precursors are vital for bacterial survival, making them a cornerstone for antibiotic development with high specificity to prokaryotes.

Other names

Peptidoglycan monomer unitsDisaccharide-peptide monomer unitUDP-MurNAc-pentapeptideLipid ILipid II (GlcNAc-MurNAc-peptide)Muramyl pentapeptide

Inhibition of transpeptidation by binding to penicillin-binding proteins (PBPs). Inhibition of glycosyltransferase activity preventing glycan chain formation. Blockade of lipid II flipping or polymerization.